Amedeo Smart

Free Medical Literature Service


 

Amedeo

Malaria

  Free Subscription

Articles published in
Nat Med
    August 2026

  1. The px1 locus is linked to declining susceptibility to malaria drugs in Uganda.
    Nat Med. 2026 Aug 19. doi: 10.1038/s41591-026-04624.
    >> Share

    July 2026
  2. O'LEARY K
    Mining antigens for a universal malaria vaccine.
    Nat Med. 2026 Jul 16. doi: 10.1038/d41591-026-00036.
    >> Share

    June 2026
  3. MSHAMU S, Mukaka M, Sanga C, Kambanga S, et al
    A sustainable house design to improve child health in rural Africa: a cluster-randomized controlled trial.
    Nat Med. 2026;32:2294-2301.
    >> Share

    April 2026
  4. WAWINA-BOKALANGA T, Makangara-Cigolo JC, Ola-Mpumbe R, Lokilo E, et al
    Deciphering the etiology of the 2024 outbreak of undiagnosed febrile illness in Panzi, Democratic Republic of the Congo.
    Nat Med. 2026;32:1374-1382.
    >> Share

    February 2026
  5. O'LEARY K
    Climate change could hinder malaria eradication efforts.
    Nat Med. 2026 Feb 13. doi: 10.1038/d41591-026-00009.
    >> Share

    January 2026
  6. KAPULU MC, Orenge F, Kimani D, Kibwana E, et al
    Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.
    Nat Med. 2026 Jan 6. doi: 10.1038/s41591-025-04107.
    >> Share

  7. ABONG'O B, Kwaro D, Bange T, Moshi V, et al
    Housing modifications for heat adaptation, thermal comfort and malaria vector control in rural African settlements.
    Nat Med. 2026 Jan 5. doi: 10.1038/s41591-025-04104.
    >> Share

    October 2025
  8. O'LEARY K
    A simple strategy to cut malaria infection rates in babies.
    Nat Med. 2025 Oct 20. doi: 10.1038/d41591-025-00061.
    >> Share


  9. Modeling the threat of pfhrp2/3 gene deletions for malaria diagnosis.
    Nat Med. 2025 Oct 10. doi: 10.1038/s41591-025-03985.
    >> Share

  10. WATSON OJ, Tran TN, Zupko RJ, Symons T, et al
    Global risk of selection and spread of Plasmodium falciparum histidine-rich protein 2 and 3 gene deletions.
    Nat Med. 2025 Oct 6. doi: 10.1038/s41591-025-03974.
    >> Share

    June 2025
  11. SKINNER J, Kayentao K, Ongoiba A, Healy SA, et al
    Anti-sporozoite monoclonal antibody for malaria prevention: secondary efficacy outcome of a phase 2 randomized trial.
    Nat Med. 2025 Jun 3. doi: 10.1038/s41591-025-03739.
    >> Share

    January 2025
  12. BOND C, Bednarski OJ, Datta D, Namazzi R, et al
    Elevated uric acid levels, mortality and cognitive impairment in children with severe malaria.
    Nat Med. 2025 Jan 24. doi: 10.1038/s41591-024-03430.
    >> Share

  13. GOSWAMI D, Kappe SHI
    Setting sights on a single-shot malaria vaccine.
    Nat Med. 2025 Jan 3. doi: 10.1038/s41591-024-03427.
    >> Share

  14. DEREJE N, Fallah MP, Shaweno T, Duga A, et al
    Resurgence of malaria and artemisinin resistance in Africa requires a concerted response.
    Nat Med. 2025 Jan 3. doi: 10.1038/s41591-024-03439.
    >> Share

  15. ROOZEN GVT, van Schuijlenburg R, Hensen ADO, Koopman JPR, et al
    Single immunization with genetically attenuated Pf?mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial.
    Nat Med. 2025 Jan 3. doi: 10.1038/s41591-024-03347.
    >> Share

    August 2024
  16. DEREJE N, Fallah MP, Ndembi N, Duga A, et al
    A community engagement framework to accelerate the uptake of malaria vaccines in Africa.
    Nat Med. 2024 Aug 22. doi: 10.1038/s41591-024-03193.
    >> Share


  17. Spillover effects of targeted malaria interventions benefit neighboring areas.
    Nat Med. 2024 Aug 15. doi: 10.1038/s41591-024-03221.
    >> Share

    July 2024
  18. BENJAMIN-CHUNG J, Li H, Nguyen A, Barratt Heitmann G, et al
    Extension of efficacy range for targeted malaria-elimination interventions due to spillover effects.
    Nat Med. 2024 Jul 4. doi: 10.1038/s41591-024-03134.
    >> Share

    June 2024
  19. O'LEARY K
    A malaria drug could help treat polycystic ovary syndrome.
    Nat Med. 2024 Jun 25. doi: 10.1038/d41591-024-00047.
    >> Share

    April 2024
  20. ISHENGOMA DS, Gosling R, Martinez-Vega R, Beshir KB, et al
    Urgent action is needed to confront artemisinin partial resistance in African malaria parasites.
    Nat Med. 2024 Apr 25. doi: 10.1038/d41591-024-00028.
    >> Share

    January 2024
  21. TAYLOR TE, Osier F
    Integrating vaccines and monoclonal antibodies into malaria prevention.
    Nat Med. 2024 Jan 10. doi: 10.1038/s41591-023-02745.
    >> Share

  22. WILLIAMS KL, Guerrero S, Flores-Garcia Y, Kim D, et al
    A candidate antibody drug for prevention of malaria.
    Nat Med. 2024 Jan 2. doi: 10.1038/s41591-023-02659.
    >> Share

    November 2023
  23. ZUPKO RJ, Nguyen TD, Ngabonziza JCS, Kabera M, et al
    Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda.
    Nat Med. 2023;29:2775-2784.
    >> Share

    October 2023
  24. EMIRU T, Getachew D, Murphy M, Sedda L, et al
    Evidence for a role of Anopheles stephensi in the spread of drug and diagnosis-resistant malaria in Africa.
    Nat Med. 2023 Oct 26. doi: 10.1038/s41591-023-02641.
    >> Share


  25. Modeling to guide drug policy response to artemisinin-resistant malaria in Rwanda.
    Nat Med. 2023 Oct 11. doi: 10.1038/s41591-023-02619.
    >> Share

    August 2023
  26. O'LEARY K
    Mosquito-inhabiting bacteria could help tackle malaria.
    Nat Med. 2023 Aug 17. doi: 10.1038/d41591-023-00073.
    >> Share

    March 2023
  27. CASTRO MC, Peterka C
    Malaria is increasing in Indigenous and artisanal mining areas in the Brazilian Amazon.
    Nat Med. 2023 Mar 27. doi: 10.1038/s41591-023-02280.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016